NeuPath Health Inc.
NPTH.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 35.47% | -204.59% | 277.49% | -97.46% | 79.75% |
| Total Depreciation and Amortization | -22.56% | -9.82% | -11.01% | -7.19% | 64.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.98% | 151.19% | 45.93% | 68.04% | -87.98% |
| Change in Net Operating Assets | -178.63% | 44,314.29% | -91.59% | 35.24% | -51.70% |
| Cash from Operations | -47.35% | 94.94% | -33.81% | 633.71% | -10.28% |
| Capital Expenditure | -117.91% | -151.44% | -1,914.10% | 64.50% | -26.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -104.88% | -110.66% | -1,914.10% | -67.55% | -26.00% |
| Total Debt Issued | -- | -- | -- | -- | 100.00% |
| Total Debt Repaid | 38.30% | 73.52% | 49.14% | 42.66% | 44.52% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -61.90% | -51.02% | -68.42% | -20.63% | 0.00% |
| Cash from Financing | 27.95% | 75.98% | -698.19% | 35.26% | 50.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -258.07% | -54.55% | -82.32% | 28.92% | 149.90% |